Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • IMPAX LABORATORIES INC Financial Overview

  • Income Statement: IPXL

      Change (  -  )
    Net Sales/Revenues 210.07 M —%
    Gross Profit —%
    Net Income Before Extra Items/Preferred Div —%
    Operating Income 11.80 M —%
  • Cash Flow: IPXL

      Change (  -  )
    Net Cash Flow - Financing -65.08 M —%
    Net Cash Flow - Investing -32.33 M —%
    Net Cash Flow/Operating Activities 64.56 M —%
  • Balance Sheet: IPXL

      Change (  -  )
    Total Assets 461.98 M —%
    Total Liabilities 302.58 M —%
    Shareholders Equity —%
  • Key Ratios / Statistics: IPXL

    • Valuation

      Price/Earnings (TTM) 28.68
      Price/Sales (TTM)
      Price/Book (MRQ) 2.98
      Price/Cash Flow (TTM) 10.69
    • Profitability

      Gross Margin
      Operating Margin
      Profit Margin
    • Dividends

      Dividend Paid (TTM)
      Payout Ratio % (TTM)
    • Financial Strength

      Quick Ratio (MRQ) 1.61
      Current Ratio (MRQ) 2.17
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) 12.58
      Return on Assets (TTM) 4.87
      Return on Investments (TTM) 10.09